glp 1 agonists canada View of Current Utilization Patterns of Glucagon-Like Peptide-1 Receptor GLP-1 Receptor Agonist Market Size
Description
It was already identified in 1993 by Morrison and colleagues (24)
doi: 10.2337/dci24-0003 [DOI] [PubMed] [Google Scholar] 133.Meissner WG, Remy P, Giordana C, et al
doi: 10.1111/dom.12596 94 GlaesnerWVickAMMillicanREllisBTschangSHTianYet al
F., Peptide Degradation and the Role of DPP4 Inhibitors in the Treatment of Type 2 Diabetes, Peptides 100 (2018): 150157, 10.1016/j.peptides.2017.10.011
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) enhance cardiometabolic health, leading to improved glycemic control, weight loss, and better cardiovascular risk profile [4]
